The authors describe some cases of container closure design flaws and actions taken by FDA to mitigate safety risks and increase patient acceptability.
The authors describe some cases of container closure design flaws and actions taken by FDA to mitigate safety risks and increase patient acceptability.
The authors describe some cases of container closure design flaws and actions taken by FDA to mitigate safety risks and increase patient acceptability.
The authors describe some cases of container closure design flaws and actions taken by FDA to mitigate safety risks and increase patient acceptability.
The authors describe some cases of container closure design flaws and actions taken by FDA to mitigate safety risks and increase patient acceptability.
The authors describe some cases of container closure design flaws and actions taken by FDA to mitigate safety risks and increase patient acceptability.
The authors present a method for controlling the release of therapeutics by applying a plasma polymer layer to the surface of porous materials.
Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.
But are innovations sufficient to increase adoption? CMOs are demanding better continuous bioprocessing options.
Real-time, continuous optimization of holistic systems improves energy efficiency and performance at manufacturing plants and laboratories.
Following the United Kingdom’s decision to leave the European Union, there are two areas that demand attention-clinical trials and marketing authorization
Best practices for buying, selling, and transporting second-user equipment.
Best practices for buying, selling, and transporting second-user equipment.
Best practices for buying, selling, and transporting second-user equipment.
Robots are becoming faster, cheaper and smaller. In pharmaceutical packaging applications, robots are often used at the end of the process — either in the primary packing of product into small packs, or further downstream product packing into cartons and subsequent palletising.
Development of viable dosage forms for poorly water-soluble compounds continues to be a significant challenge for formulation scientists, and insufficient bioavailability of such compounds may result in development delays or failures.
Understanding the components of a reference marketed pMDI is needed to develop a generic pMDI.
Requirements for virus filtration must be considered in developing continuous downstream processes.
Requirements for virus filtration must be considered in developing continuous downstream processes.
The integration of a method validation, transfer, and verification process into the overall lifecycle management process of a product can best align the variability of the analytical procedure with the requirements of the product.
The inVia™ Qontor® microscope's optical tweezing performance depends on the optical properties of the particles and the medium. Typically, it can trap particles smaller than 10 ?m.
Shear-sensitive ingredients in a tableting formulation experience different conditions in a batch tumble blender than they would in a continuous paddle blender.
Attend this webcast to hear Jacob Butler, quality control specialist at Organon Teknika Merck, describe his experience with manual solvent and oven extraction method development. Jacob will present a case study that demonstrates both determination of optimal oven temperatures and how to build an oven method for method validation. Live: Wednesday, Aug. 14, 2019 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until Aug. 14, 2020 Register free
Are investigations supporting or hindering performance excellence?
Using risk assessment properly can provide industry with a unique tool for quality control.
A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.
Consider the purity of exhaust air emitted by vacuum pumps in addition to the purity of compressed air used in the pharmaceutical process.
Shear-sensitive ingredients in a tableting formulation experience different conditions in a batch tumble blender than they would in a continuous paddle blender.